Valproic Acid News and Research

RSS
Valproic Acid is a drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of Kaposi sarcoma. It is a type of anticonvulsant, antimaniacal, and migraine headache prophylactic.
Study examines effects of AEDs on nicotine metabolite levels in smokers

Study examines effects of AEDs on nicotine metabolite levels in smokers

Valproic acid halts vision loss in patients with retinitis pigmentosa

Valproic acid halts vision loss in patients with retinitis pigmentosa

Landmark clinical trial examines effective treatment options for childhood epilepsy

Landmark clinical trial examines effective treatment options for childhood epilepsy

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Embryonic stem cells raise hope of cellular replacement therapy for liver failure

Embryonic stem cells raise hope of cellular replacement therapy for liver failure

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Epilepsy drug may raise the risk of birth defects

Epilepsy drug may raise the risk of birth defects

Taking the epilepsy drug topiramate may increase risk of birth defects

Taking the epilepsy drug topiramate may increase risk of birth defects

People with manic depression have a distinct chemical signature in their brains

People with manic depression have a distinct chemical signature in their brains

Enzyme important in fetal heart-cell failure - findings provide new targets for treatment

Enzyme important in fetal heart-cell failure - findings provide new targets for treatment

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

Environmental scientists identify new culprits in the cancer equation

Environmental scientists identify new culprits in the cancer equation

Valproic acid may help slow the progression of dementia

Valproic acid may help slow the progression of dementia

Repligen commences phase 2 trial of RG2417 for bipolar depression

Repligen commences phase 2 trial of RG2417 for bipolar depression

$1 million of mesothelioma research funding

$1 million of mesothelioma research funding